J
James Dziura
Researcher at Yale University
Publications - 312
Citations - 23940
James Dziura is an academic researcher from Yale University. The author has contributed to research in topics: Randomized controlled trial & Medicine. The author has an hindex of 68, co-authored 281 publications receiving 21238 citations. Previous affiliations of James Dziura include Tufts University & University of California, Los Angeles.
Papers
More filters
Journal ArticleDOI
Effective Translation of an Intensive Lifestyle Intervention for Hispanic Women With Prediabetes in a Community Health Center Setting
Michelle A. Van Name,Anne W. Camp,Elizabeth Magenheimer,Fangyong Li,James Dziura,Abmaridel Montosa,Anisha Patel,William V. Tamborlane +7 more
TL;DR: A 14-week ILI program based on the DPP can effectively be translated into a predominantly Hispanic CHC setting, resulting in decreased weight, improved fasting insulin, and smaller glucose excursions 1 year after enrolling in the program.
Journal ArticleDOI
Renal Ultrasonography in the Evaluation of Acute Kidney Injury: Developing a Risk Stratification Framework
Adam Licurse,Michael C. Kim,James Dziura,Howard P. Forman,Richard N. Formica,Danil V. Makarov,Chirag R. Parikh,Cary P. Gross +7 more
TL;DR: Specific factors can identify patients unlikely to have HN or HNRI on RUS, and a multivariable logistic regression model was developed to create risk strata for HN and HN requiring an intervention (HNRI).
Journal ArticleDOI
Effect of a successful intensive lifestyle program on insulin sensitivity and glucose tolerance in obese youth.
TL;DR: An intensive lifestyle program that successfully reduces body weight and body fat can markedly improve insulin sensitivity and glucose metabolism in obese youth.
Journal ArticleDOI
Integrated stepped alcohol treatment for patients with HIV and alcohol use disorder: a randomised controlled trial.
E. Jennifer Edelman,Stephen A. Maisto,Nathan B. Hansen,Nathan B. Hansen,Christopher J. Cutter,James Dziura,Yanhong Deng,Lynn E. Fiellin,Patrick G. O'Connor,Roger Bedimo,Cynthia L. Gibert,Vincent C. Marconi,David Rimland,Maria C. Rodriguez-Barradas,Michael S. Simberkoff,Janet P. Tate,Janet P. Tate,Amy C. Justice,Amy C. Justice,Kendall J. Bryant,David A. Fiellin +20 more
TL;DR: ISAT increases the receipt of alcohol treatment medications and counselling without changes in drinking at week 24 and future efforts should focus on promoting ISAT with attention to enhancing patient engagement and retention in alcohol-related care.
Journal ArticleDOI
Effects of simvastatin and oral contraceptive agent on polycystic ovary syndrome: Prospective, randomized, crossover trial
TL;DR: Simvastatin improved endocrine/clinical aspects of PCOS and had beneficial effects on lipid profile and markers of systemic inflammation.